HBV as a target for CAR or TCR-T cell therapy
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference55 articles.
1. Chimeric antigen receptor T-cell approaches to HIV cure;Kuhlmann;Curr Opin HIV AIDS,2018
2. Global elimination of chronic hepatitis;Thomas;N Engl J Med,2019
3. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013;Stanaway;Lancet,2016
4. Therapeutic strategies for hepatitis B virus infection: towards a cure;Fanning;Nat Rev Drug Discov,2019
5. Adaptive immunity in HBV infection;Bertoletti;J Hepatol,2016
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Applications of cell therapy in the treatment of virus-associated cancers;Nature Reviews Clinical Oncology;2024-08-19
2. Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions;Clinical and Translational Medicine;2024-06-27
3. The recent advancement of TCR-T cell therapies for cancer treatment;Acta Biochimica et Biophysica Sinica;2024-03-01
4. New facet of CARs: HBV-specific CARs as inhibitors of virus morphogenesis and release;Gut;2024-01-22
5. The expanded application of CAR-T cell therapy for the treatment of multiple non-tumoral diseases;Protein & Cell;2023-12-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3